Article
Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia.
Haematologica - 1 Feb 2018
Plešingerová Hana, Janovská Pavlína, Mishra Archana, Smyčková Lucie, Poppová Lucie, Libra Antonín, Plevová Karla, Ovesná Petra, Radová Lenka, Doubek Michael, Pavlová Šárka, Pospíšilová Šárka, Bryja Vítězslav
Abstract excerpt
Chronic lymphocytic leukemia is a disease with up-regulated expression of the transmembrane tyrosine-protein kinase ROR1, a member of the Wnt/planar cell polarity pathway. In this study, we identified COBLL1 as a novel interaction partner of ROR1. COBLL1 shows clear bimodal expression with high levels in chronic lymphocytic leukemia patients with mutated IGHV and approximately 30% of chronic lymphocytic leukemia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
